U.S. Hospitality Stock News

Over the last 7 days, the United States market has remained flat, but it has shown a substantial rise of 28% over the past 12 months with earnings forecasted to grow by 16% annually. In this context, growth companies with high insider ownership such as Cardinal Infrastructure Group can be particularly appealing as they often indicate confidence from those closest to the company in its future performance.

In the last week, the United States market has stayed flat, but it has risen by 28% over the past year with earnings forecasted to grow by 16% annually. In this dynamic environment, identifying promising small-cap stocks can offer unique opportunities for investors seeking growth potential beyond well-known large-cap companies.

The United States market has remained flat over the last week, but it has experienced a notable 28% rise over the past 12 months, with earnings forecasted to grow by 16% annually. In these conditions, dividend stocks that offer consistent payouts and have strong fundamentals can be an appealing choice for investors seeking stability and income.

Auditor change at REalloys (ALOY) draws fresh attention to rare earth supply risks Interest in REalloys (ALOY) has picked up as investors weigh recent disruptions at the Strait of Hormuz and renewed focus on rebuilding a domestic rare earth supply chain for defense and technology uses. At the same time, REalloys disclosed that its audit committee approved the dismissal of Victor Mokuolo CPA PLLC and the appointment of Grassi & Co. CPAs, P.C. as its new independent registered public accounting...

This article walks through key numbers to help you assess whether Marvell Technology's recent share price suggests a bargain or a stretch valuation. The stock last closed at US$164.95, with reported returns of 4.3% over 7 days, 54.0% over 30 days, 84.5% year to date and 166.9% over the past year, plus 306.3% over 3 years and 279.5% over 5 years. Recent coverage has focused on Marvell Technology's role in areas like semiconductors and related infrastructure. Many investors watch these areas...

In the first quarter of 2026, Upbound Group reported revenue of US$1.22 billion and net income of US$35.79 million, while reaffirming its full‑year 2026 revenue guidance of US$4.70 billion to US$4.95 billion. Alongside stronger earnings, Upbound’s Rent‑A‑Center business entered an Amazon pickup and returns agreement, highlighting how partnerships may support store traffic and customer engagement. Next, we’ll examine how Upbound’s reaffirmed 2026 outlook and new Amazon partnership shape the...

In April 2026, Leonardo DRS introduced a 2 kVA, IP54-hardened, military-qualified AC uninterruptible power supply for shipboard mission-critical electronics, while also integrating its Maritime Mission Equipment Package counter‑UAS solution onto an autonomous unmanned surface vessel for maritime threat protection. By pairing ruggedized power systems with AI-enabled maritime counter‑drone capabilities and showcasing them across major defense conferences, the company is emphasizing its role in...

In recent days, Fubo has been highlighted as the live-streaming platform for a slate of major sports events, ranging from MLB matchups to Serie A fixtures and the Manchester United vs Liverpool clash in Canada, as well as WNBA preseason action. This clustering of high-profile broadcasts across different leagues and regions underscores Fubo’s growing role as a go-to destination for live sports streaming without traditional cable. We’ll now explore how this expanded live sports coverage,...

DENTSPLY SIRONA (XRAY) heads into its upcoming quarterly report with expectations for a year on year revenue decline, as Ariel Investments and Vanguard disclose fresh positions that spotlight institutional interest. See our latest analysis for DENTSPLY SIRONA. At a share price of US$11.81, DENTSPLY SIRONA has a 1 month share price return of 1.55%. However, a 1 year total shareholder return decline of 11.41% signals that longer term momentum has been weak despite recent institutional interest...

In recent trading, Expeditors International of Washington was caught in a broad freight and logistics selloff tied to concerns about slowing global trade and softer shipping demand. Its comparatively smaller decline versus many freight peers highlights how investors may view Expeditors as relatively defensive within a pressured sector. Next, we will examine how sector-wide freight weakness and worries about softer shipping volumes shape Expeditors’ broader investment narrative. Uncover...

RLJ Lodging Trust has reported first-quarter 2026 results, with sales rising to US$275.26 million and total revenue to US$339.98 million, but shifting from a US$3.36 million net profit a year earlier to a small US$0.141 million net loss. This move into a slight loss, despite higher revenue and against a backdrop of urban market cost pressures, raises questions about how effectively the company is converting its top-line growth into sustainable profitability. We’ll now examine how this move...

Kodiak AI stock: what recent performance tells you Kodiak AI (KDK) has drawn attention after a mixed stretch in the stock, with a small single day decline, a drop over the past week, a gain over the past month, and weaker returns over the past year. See our latest analysis for Kodiak AI. With the share price at $8.35, Kodiak AI’s 30 day share price return of 12.53% contrasts with a year to date share price return of 22.90% and a 1 year total shareholder return of 25.84%. This suggests recent...

Materion (MTRN) caught investor attention after a strong first quarter, with revenue of US$549.82 million, record EBITDA margins and its highest-ever order backlog, as semiconductor, aerospace and defense demand supported performance. See our latest analysis for Materion. The strong Q1 earnings beat, record order backlog and increased institutional interest from investors such as Vanguard have lined up with powerful momentum, with a 30-day share price return of 26.22% and a 1-year total...

Event driven spotlight on Genuine Parts stock Genuine Parts (GPC) has moved back onto investor radars after its annual shareholder meeting, where the company outlined plans to separate its automotive and industrial businesses into two independent, publicly traded companies. This planned split, paired with a higher 2026 dividend and reaffirmed guidance, provides a fresh set of milestones to monitor when comparing Genuine Parts stock with your income and total return goals. See our latest...

In the first quarter of 2026, Chipotle Mexican Grill reported revenue of US$3,088.24 million, up from US$2,875.25 million a year earlier, while net income fell to US$302.82 million and the company continued expanding with plans for 350 to 370 new restaurant openings this year. Alongside fresh leadership appointments in brand and digital, Chipotle ramped up menu innovation with the return of its ChipotleHoney Chicken, enhanced its loyalty program, expanded technology pilots like...

In recent weeks, Hewlett Packard Enterprise has reported strong Q1 FY2026 results, lifted its full-year outlook, and highlighted surging AI infrastructure demand and networking growth following the Juniper integration. At the same time, HPE has expanded its ProLiant edge portfolio with rugged, AI-ready servers and new security offerings, underscoring a push into mission-critical, distributed environments where reliability and governance are central. Next, we’ll explore how this combination...

In recent weeks, Arrow Electronics has attracted attention as earnings estimates edged higher and research firm Zacks assigned the stock a Rank #2 (Buy) with a Momentum Style Score of B, alongside new SEC filings showing Vanguard entities holding passive stakes above 5% of outstanding shares as of March 31, 2026. This combination of incremental earnings upgrades, favorable momentum indicators, and sizeable passive institutional ownership highlights shifting sentiment toward Arrow’s...

IDEAYA Biosciences recently announced that the FDA has agreed to review its New Drug Application for darovasertib combined with crizotinib in first-line HLA*A2-negative metastatic uveal melanoma under the Oncology Center of Excellence Real-Time Oncology Review program, following positive Phase 2/3 OptimUM-02 trial results that met the study’s primary endpoint. This regulatory milestone highlights darovasertib’s potential to address a genetically defined segment of a rare eye cancer with...

In late April 2026, Klaviyo launched Custom Skills for its Customer Agent, allowing brands to extend the AI agent beyond standard order tracking, returns, and product recommendations by defining plain‑language logic and connecting to any system in their tech stack. This update lets businesses tailor AI‑driven customer service to their specific policies and workflows, creating experiences that align more closely with their individual brand models and CRM data. We’ll now examine how this new...

In recent weeks, FuelCell Energy unveiled a standardized 12.5 MW “Power Block” aimed at AI and cloud data centers and outlined plans to more than triple its Connecticut manufacturing capacity to serve a rapidly expanding pipeline that is now heavily weighted toward digital infrastructure projects. This shift toward modular, on-site data center power marks a meaningful evolution in how FuelCell Energy positions its fuel cell technology within the broader race to secure reliable electricity...

In the first quarter of 2026, nVent Electric plc reported record sales of US$1,242 million, up from US$809.3 million a year earlier, with earnings per share from continuing operations rising despite total net income being lower than the prior year. The results were powered by surging data center and infrastructure demand, prompting nVent to raise its full-year sales and earnings guidance while ramping capacity, including a new Blaine, Minnesota facility. We’ll now examine how this guidance...

In late April and early May 2026, Neurocrine Biosciences reported new two-year Phase 3 CAHtalyst data showing that CRENESSITY (crinecerfont) provided durable androgen control and allowed sustained reductions in glucocorticoid dosing in both adult and pediatric patients with classic congenital adrenal hyperplasia. The extended data also linked CRENESSITY use to clinically meaningful improvements in outcomes tied to excess androgens and long-term steroid exposure, strengthening its profile as...

In late April 2026, Merit Medical Systems reported first-quarter 2026 results showing US$381.88 million in sales and US$41 million in net income, with both basic and diluted earnings per share from continuing operations rising versus a year earlier and adjusted earnings and margins coming in ahead of analyst expectations. At the same time, the company slightly raised its full-year 2026 revenue guidance to about US$1.62 billion and expanded its oncology platform through the Viewpoint Medical...

In the first quarter of 2026, Proto Labs, Inc. reported revenue of US$139.34 million and net income of US$8.11 million, with diluted earnings per share from continuing operations of US$0.33, all higher than a year earlier. The company paired these record quarterly results with guidance calling for 6% to 8% revenue growth in 2026 and stronger second-quarter earnings, underscoring how its transformation efforts and demand for CNC machining are influencing its financial profile. We’ll now...